Academic literature on the topic 'Rhbmp2'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Rhbmp2.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Rhbmp2"
Colange, Ana Lucia, Carlos Sabino de Oliveira, Benedito Domingos Neto, Heloisa Sobreiro Selistre de Araújo, Eliane Trovatti, and Monica Rosas da Costa Iemma. "Effect on viability and cellular proliferation of rhBMP-2 immobilized on TEMPO modified cellulose hydrogel." Research, Society and Development 11, no. 11 (August 29, 2022): e471111133260. http://dx.doi.org/10.33448/rsd-v11i11.33260.
Full textJeong, Byung-Chul, Hyuck Choi, Sung-Woong Hur, Jung-Woo Kim, Sin-Hye Oh, Hyun-Seung Kim, Soo-Chang Song, Keun-Bae Lee, Kwang-Bum Park, and Jeong-Tae Koh. "Repair of Cranial Bone Defects Using rhBMP2 and Submicron Particle of Biphasic Calcium Phosphate Ceramics with Through-Hole." BioMed Research International 2015 (2015): 1–9. http://dx.doi.org/10.1155/2015/926291.
Full textAlobaidaan, Raed, Jeremiah R. Cohen, Elizabeth L. Lord, Zorica Buser, S. Tim Yoon, Jim A. Youssef, Jong-Beom Park, Darrel S. Brodke, Jeffrey C. Wang, and Hans-Joerg Meisel. "Complication Rates in Posterior Lumbar Interbody Fusion (PLIF) Surgery With Human Bone Morphogenetic Protein 2: Medicare Population." Global Spine Journal 7, no. 8 (May 16, 2017): 770–73. http://dx.doi.org/10.1177/2192568217696695.
Full textPor, Yong-Chen, Carlos Raul Barceló, Kenneth E. Salyer, David G. Genecov, Karen Troxel, El Gendler, Mohammed E. Elsalanty, and Lynne A. Opperman. "Bone Generation in the Reconstruction of a Critical Size Calvarial Defect in an Experimental Model†." Annals of the Academy of Medicine, Singapore 36, no. 11 (November 15, 2007): 911–19. http://dx.doi.org/10.47102/annals-acadmedsg.v36n11p911.
Full textPatel, Harshadkumar A., Ian J. Wellington, Klair Lubonja, John W. Stelzer, Christopher L. Antonacci, Ergin Coskun, Mark P. Cote, Hardeep Singh, Scott S. Mallozzi, and Isaac L. Moss. "Current Trends in Recombinant Human Bone Morphogenetic Protein 2 (rhBMP2) Usage for Spinal Fusion Surgery." Medicina 59, no. 5 (May 3, 2023): 878. http://dx.doi.org/10.3390/medicina59050878.
Full textFujioka-Kobayashi, Masako, Mustafa Abd El Raouf, Nikola Saulacic, Eizaburo Kobayashi, Yufeng Zhang, Benoit Schaller, and Richard J. Miron. "Superior bone-inducing potential of rhBMP9 compared to rhBMP2." Journal of Biomedical Materials Research Part A 106, no. 6 (February 19, 2018): 1561–74. http://dx.doi.org/10.1002/jbm.a.36359.
Full textFujioka‐Kobayashi, Masako, Mustafa Abd El Raouf, Nikola Saulacic, Eizaburo Kobayashi, Yufeng Zhang, Benoit Schaller, and Richard J. Miron. "Superior bone‐inducing potential of rhBMP9 compared to rhBMP2." Journal of Biomedical Materials Research Part A 107, no. 6 (May 3, 2019): 1351. http://dx.doi.org/10.1002/jbm.a.36591.
Full textZhao, He, Yali Ma, Dahui Sun, Wendi Ma, Jihang Yao, and Mei Zhang. "Preparation and Characterization of Coaxial Electrospinning rhBMP2-Loaded Nanofiber Membranes." Journal of Nanomaterials 2019 (August 29, 2019): 1–13. http://dx.doi.org/10.1155/2019/8106985.
Full textLao, Lifeng, Jeremiah R. Cohen, Zorica Buser, Darrel S. Brodke, S. Tim Yoon, Jim A. Youssef, Jong-Beom Park, Hans-Joerg Meisel, and Jeffrey C. Wang. "Trends Analysis of rhBMP2 Utilization in Single-Level Anterior Lumbar Interbody Fusion in the United States." Global Spine Journal 8, no. 2 (May 16, 2017): 137–41. http://dx.doi.org/10.1177/2192568217701119.
Full textEsmail, Nabil, Zorica Buser, Jeremiah R. Cohen, Darrel S. Brodke, Hans-Joerg Meisel, Jong-Beom Park, Jim A. Youssef, Jeffrey C. Wang, and S. Tim Yoon. "Postoperative Complications Associated With rhBMP2 Use in Posterior/Posterolateral Lumbar Fusion." Global Spine Journal 8, no. 2 (April 20, 2017): 142–48. http://dx.doi.org/10.1177/2192568217698141.
Full textDissertations / Theses on the topic "Rhbmp2"
Valenzuela, Juan Carlos Bustos. "Análise dos genes diferencialmente expressos durante a osteodiferenciação induzida por proteínas morfogenéticas de osso (BMP2 e BMP7) em células C2C12 e super-expressão de rhBMP2 e rhBMP7 em células de mamíferos." Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/46/46131/tde-31072009-140027/.
Full textThe BMPs (Bone Morphogenetic Proteins) are members of the TGF-β (Transforming Growth Factor β) superfamily of proteins, regulate growth and differentiation of various cell types in various tissues, and some play a critical role in differentiation of mesenchymal cells into osteoblasts. Particularly, rhBMP2 and rhBMP7, promote osteoinduction \"in vitro\" and \"in vivo\" and both proteins are used therapeutically in Orthopedics and Dentistry. The differential expression of genes during osteodifferentiation induced by rhBMP2 and rhBMP7 in C2C12 cells was analyzed through DNA microarrays, allowing the selection of 31 genes, of which 24 were validated by qPCR, 13 of which are related to transcription, four associated with cell signaling pathways and seven are associated with the extracellular matrix. Subsequent functional analysis of these genes should reveal more details on the molecular events which take place during C2C12 cells osteoblastic differentiation induced by rhBMPs In paralel, rhBMPs 2 and 7 were overexpressed in HEK293T cells and BMP7 activity to induce osteodifferentiation \"in vitro\" and bone formation \"in vivo\" was demonstrated, reinforcing the viability of our objective to produce these proteins for future application as biopharmaceuticals in Brazil.
LECOEUR, ALAIN DIT LOIC. "Etude de l'induction de la differenciation osteoblastique sur les cellules stroma-vasculaires de tissu adipeux extramedullaire en culture sous l'influence de la proteine recombinante humaine rhbmp2 et de la dexamethasone : chez le lapin et chez l'humain." Paris 7, 1997. http://www.theses.fr/1997PA07GA06.
Full textGonzaga, Miliane Gonçalves. "Estudo qualitativo e quantitativo da interação entre a proteína morfogenética rhBMP-2 e diferentes tipos de enxertos ósseos." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/17/17142/tde-29052015-110800/.
Full textProteins with osteoinductive potential, particularly the rhBMP-2, have great effects on growth and cell differentiation. This study aimed to evaluate the relationship between different bone grafts and rhBMP-2 on the repair of critical bone defects in rat skulls. Fifty six Wistar rats, male, approximately 250g of body weight were used, sacrificed six weeks after surgical experiment, and divided into 8 groups(n=7): autograft (AUT); homograft (HOM); xenograft (HET); autograft and 5 g rhBMP-2 (AUT BMP); homograft and 5 g rhBMP-2 (HOM BMP); xenograft and 5 g rhBMP-2 (HET BMP); 5 g rhBMP-2 (BMP) and critical bone defect only (DOC). The results were analyzed statistically by ANOVA and Tukey post-test with multiple comparisons (p<0.05 of significance level), after the use of qualitative methodologies, micro CT morphology and histological analysis. According to the quantification of newly formed bone volume, all groups had better results than DOC group with a significant difference. The HOM and HET groups showed significant difference than AUT BMP, HOM BMP and HET BMP, that had higher bone formation, while AUT group was significantly different from HOM BMP and HET BMP. The BMP group had no significant difference in relation to AUT, HOM, HET, AUT BMP, HOM BMP and HET BMP. The AUT, HOM and HET groups had no significant difference between them, and also the groups AUT BMP, HOM BMP and HET BMP between them. Regarding the quantification of osteoclasts, there was no significant difference between groups; however, HET BMP had more osteoblastic cells than DOC group, with significant difference. For osteocytes quantification, AUT and DOC showed few cells. Thus, DOC had significant difference in relation to BMP, HET, HOM BMP and HET BMP; and AUT had significant difference in relation to BMP, HET, HOM BMP and HET BMP. Likewise, AUT BMP had significant difference compared to HET group, which showed more cells. Regarding to collagen fibers quantification, there was no significant difference between groups. New bone formation progressed from the edges to the center of the defect and for BMP group the newly formed bone occupied more than two thirds of the defect. DOC group showed a narrow band of newly formed bone at the edges and the remainder of the defect was filled by connective tissue. For micro CT analysis, all groups showed greater bone formation than the DOC group, being greater in AUT group than HOM and HET. Furthermore, the various grafts associated with rhBMP-2 showed greater bone formation than the isolated grafts, highlighting the AUT BMP. Therefore, it was concluded that rhBMP-2 helped bone repair when administered alone or associated with different bone grafts, giving better results when combined to the grafts
Freitas, Maria da Conceição Andrade de. "Análise histológica da região alveolar enxertada com rhBMP-2 em pacientes com fissuras labiopalatinas." Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/61/61132/tde-06062017-085349/.
Full textObjective: This study aimed to evaluate histologically the bone and soft tissue removed from the region of the rhBMP-2-grafted alveolar cleft in patients with cleft lip and palate 6 to 46 months after surgery. Material and Methods: The experimental group consisted of 13 patients with canines retained in the alveolar region grafted with rhBMP-2 (Infuse®). The control group consisted of six patients with canines retained in the contralateral alveolar region or near the ungrafted cleft and one with canine retained in the grafted area with autogenous iliac crest bone. At the time of surgical exposure of the canine, 6 to 46 months after secondary bone graft, biopsies of bone and soft tissues were submitted to histological analysis by the hematoxylin and eosin technique. Results: The microscopic sections (n = 12) showed fragments of viable bone tissue with normal osteocytes in gaps, osteoblasts in the bone surface and spinal spaces filled by fibrous connective tissue and blood vessels. The bone tissue biopsies removed at a 6 to 9 months after grafting showed more disorganized bone trabeculae, with no lamellar formations and with a higher osteocyte density per area indicating a lower degree of bone maturity. Biopsies taken from 24 to 46 months after grafting were composed only for mature lamellar bone tissue containing reversion / incremental lines and osteocyte gaps. Soft tissue sections (n= 3) revealed fragments of buccal mucosa consisting of parakeratinized stratified squamous epithelium with fibrous connective tissue. Conclusion. Fragments of bone and soft tissues removed from the rhBMP-2 grafted cleft area showed normal histological morphology, resembling tissue characteristics on the control group.
Leal, Claudia Resende. "Enxerto alveolar com proteína morfogenética óssea (rhBMP-2) na fissura labiopalatina: influência da idade, do cirurgião, do tipo e da amplitude da fissura." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/61/61132/tde-17102016-142925/.
Full textObjective: To evaluate whether the canine irruption stage at the time of surgery, the type and width of cleft lip and palate and the surgeon influence on the outcome of alveolar graft surgeries performed with bone morphogenetic protein (rhBMP-2). Material and methods: This cross-sectional study evaluated a sample 90 individuals who consecutively underwent alveolar graft surgery with rhBMP-2 in a single center. Periapical radiographs were taken before and 6 months after surgery. Four experienced surgeons operated all patients. The result of alveolar graft was characterized in success or failure by three raters based on the criteria adopted by both the modified Bergland and Chelsea scales. The canine irruption stage at the time of the procedure, the type and width of cleft lip and palate and the surgeon who performed the surgery were considered. The larger width of the alveolar cleft was measured on periapical radiographs taken preoperatively using the software VISTA perio-plus scan (Dürr Dental, Bietigheim-Bissingen, Germany). Intra and inter-rater agreements were evaluated using Kappa coefficient. The intra-rater agreement for the variable cleft width was evaluated using Dahlberg test, paired t-tests and the Intraclass Correlation Coefficient (ICC). The influence of the independent variables in the outcome of alveolar graft was analyzed using Multivariate Logistic Regression (p<0.05). Results: All independent variables were statistically significant. The unerupted canine group showed better results than the erupted canines group (p=0.001). Cleft lip and alveolus group showed better outcomes than the complete cleft lip and palate group (p = 0.000). The larger the alveolar cleft width, the poorer the outcome of the alveolar graft (p = 0.027). The surgeon also had a significant influence on the success of the surgery (p = 0.003 and 0.001). Conclusion: The canine irruption stage, the type and width of cleft lip and palate and the surgeon influenced the outcome of alveolar graft surgeries performed with rhBMP-2.
Kotake, Bruna Gabriela dos Santos. "Avaliação da reparação óssea em defeitos críticos após a aplicação da proteína rhBMP-2 pura e/ou combinada em animais normais e sob efeito do alcoolismo crônico." Universidade de São Paulo, 2012. http://www.teses.usp.br/teses/disponiveis/58/58137/tde-04122012-164616/.
Full textAlcoholism is considered a reducer for new bone formation, may leading to osteometabolic disturbance, considering that the rhBMP-2 is a morphogenetic protein known to play an important role in the bone healing processes. The aim of this study was to investigate the action of alcoholism and its effect on the repair of bone defects (DO) performed in rat calvaria after the rhBMP-2 application, pure or combined with a collagen matrix. We used 80 rats divided into eight groups, each one with a waiting period for sacrifice of 4 and 6 weeks after the bone defect (5mm) delineation in the rat skull. The groups were divided into: G1) water \"ad libitum\" + DO, G2) alcohol \"ad libitum\" + DO, G3) water + DO + 5μg pure rhBMP-2, G4) alcohol + DO + 5μg pure rhBMP-2, G5 ) DO + water + collagen sponge carrier, G6) alcohol + DO + collagen sponge carrier, G7) and water + DO + 5μg rhBMP-2/collagen sponge, G8) alcohol + DO + 5μg of rhBMP-2/collagen sponge. The radiographic data were submitted to statistical analysis Kruskal-Wallis and Dunn\'s Multiple, histological data to analysis of variance (ANOVA) and Tukey test. Radiographically, it was found after 6 weeks that the groups treated with rhBMP-2, independently of the carrier use and ethanol administration, more new bone formation (p<0.05), at 4 weeks it was not found statistical difference. For immunohistochemical analysis, ostecalcin (OC), and bone sialoprotein (BPS) were predominant in groups treated with rhBMP-2. For histological quantification of collagen type I fibers, statistical difference between groups was found (p<0.05) with the increasing of these fibers in the groups treated with rhBMP-2 combined with collagen sponge; and quantitative by stereology, aiming to calculate the volume of new bone, it was found higher values for the groups treated with rhBMP-2 pure or combined to the carrier; but for the groups treated with ethanol, it was found higher bone formation in the groups treated with rhBMP-2 associated to the carrier in the periods of 4 and 6 weeks (p <0.001). It was concluded in this experimental model that the carrier was effective for rhBMP-2 delivery, even in the presence of ethanol.
Izadpanah, Ali. "Effect of rhBMP-7 dosing during distraction osteogenesis in wild type mice." Thesis, McGill University, 2011. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=103541.
Full textL'ostéogenèse par distraction (DO) est une technique courante de chirurgie pour l'allongement des os dans le traitement des anomalies des membres, des malformations congénitales, de la perte osseuse traumatique, des infections et des tumeurs malignes. Elle est composée de trois phases principales: la phase de latence, la phase de distraction, et la phase de consolidation. DO amène cependant plusieurs inconvénients. Le principal inconvénient de l'ostéogenèse par distraction est la longue période de solidification. Ainsi, toute tentative visant à raccourcir ce processus serait grandement bénéfique. Les protéines morphogénétiques osseuses (BMP) sont cruciales au développement des os et du cartilage. Il a récemment été démontré que la BMP-7 a un effet bénéfique sur la formation osseuse au cours de distraction osseuse sur des rats. Cependant, il n'existe pas d'études pour trouver la dose optimale d'injection de BMP-7. Par conséquent, nous avons cherché à déterminer la dose optimale d'administration de BMP-7 exogène au cours de DO. À cette fin, DO a été effectuée sur le tibia droit de 79 souris mâle sauvages (C57BL / 6) en utilisant une version miniature du fixateur Ilizarov. Les animaux ont été séparés au hasard en deux groupes principaux en fonction du moment d'euthanasie; 45 souris ont été euthanasiées à la mi-solidification et 34 ont été euthanasiées à la fin de la solidification. Chaque groupe a ensuite été subdivisé en fonction de la dose administrée de BMP-7. Trois doses différentes de BMP-7 ont été injectées sur le site de l'ostéotomie au premier jour de la distraction (0.05μg, 0.10μg, 0.50μg correspondant à 2μg/kg, 4μg/kg et 20μg/kg de BMP-7). Les groupes de contrôle ont été injectés avec de l'eau pure. Des échantillons ont été collectés à deux points dans le temps: 34 jours (mi-solidification) et 51 jours (fin de la solidification). Les échantillons prélevés ont été étudiés à l'aide d'un rayon-X Faxitron, d'un μCT, de l'histomorphométrie statique, d'essais biomécaniques, de l'immunohistochimie, et de l'histologie. Les résultats ont démontré qu'il y a un effet réducteur pour accélérer la formation osseuse au cours de distraction osseuse avant l'augmentation de la dose de BMP-7 au mi-solidification. L'analyse μCT et les paramètres histomorphométrie statiques ont révélé une diminution statistiquement significative du volume osseux/volume des tissus (BV/TV) et de la régénération osseuse avant l'augmentation de la dose de BMP-7. L'évaluation biomécanique au 34ième jours a également démontré une plus grande rigidité et de travail ultime avant rupture à la plus faible dose administrée de BMP-7. D'autre part, au fin de la solidification, les résultats histomorphométriques statiques et μCT ont démontré la plus grande BV/TV à la dose moyenne d'administration de 4μg/kg (30.09 ± 4,076, 1,533 ± 38,73, 27,02 ± 2,684 et 17,68 ± 3,808 pour 2μkg, 4μg/kg, 20μg/kg, et le contrôle, respectivement). De même, la formation de osseuse avait des résultats comparables (4,062 ± 0,4874, 6,969 ± 1,123, 4,946 et 0,6362 ± pour 2μkg, 4μg/kg et 20μg/kg respectivement). Les essais biomécaniques sur les échantillons prélevés au fin de la solidification ont démontré une diminution progressive de la rigidité (63,72 ± 35,03, 45,56 ± 8,045, 28,99 ± 11,22 et 35,49 ± 17,00 pour 2μkg, 4μg/kg, 20μg/kg, et le contrôle, respectivement) et la force ultime avant rupture (13,69 ± 5,149, 2,086 ± 13,12, 8,815 ± 2,972, 8,188 et 3,334 ± pour 2μkg, 4μg/kg, 20μg/kg, et le contrôle, respectivement) après l'augmentation de la dose. En conclusion, les résultats de cette étude suggèrent que la BMP-7 exerce un rôle physiologique important dans la régénération osseuse au cours de la DO. Également, nous avons démontré qu'avec l'augmentation de la dose administrée, la quantité de formation osseuse et de BV sont à la baisse. Ces résultats sont comparables avec les évaluations biomécaniques obtenus à mi-solidification et fin de la solidification.
Schwartz, Daniel. "Development of an Aqueous Suspension of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)." Diss., lmu, 2005. http://nbn-resolving.de/urn:nbn:de:bvb:19-44316.
Full textJohnson, Trenton. "Effect of guided bone regeneration with rhBMP-2 on bone quality surrounding dental implants." The Ohio State University, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=osu152147382891412.
Full textLucia, Conrado Ingraci de. "Análise quantitativa dos níveis de cálcio, Colagenase A e B durante o reparo ósseo em calvárias de ratos sob o modelo experimental de defeito ósseo." Universidade de São Paulo, 2013. http://www.teses.usp.br/teses/disponiveis/58/58137/tde-03042013-163708/.
Full textBone is a special tissue with a high mineral content and performs various functions in the body, such as calcium reserves, protection of vital structures and muscles lever during the movement. Bone constantly undergoes remodeling processes, which keeps its functional structure and repair small fractures that commonly occur due to the stress of continuous use. The repair system works perfectly synchronized by the cells that produce bone components and resorbing cells, allowing the perfect tissue organization. This maintenance system depends on the interaction between these cells and the signals sent by mediators and modulators. Several proteins operate to induce bone formation, but also to facilitate the reconstruction. Among these proteins are the BMPs, which have great osteoinductive potential, and MMPs that act at different stages of construction and maintenance of this tissue. Particularly BMP-2 has shown significant potential in terms of induction and its recombinant form, rhBMP-2, produced by recombinant engineering, has been released for clinical use and commercialization. In relation to MMPs, there are important functions of MMP-2 and MMP-9 in this tissue. First, structuring the matrix and modulating the resorption during inflammatory processes inherent to repair; second, acting at early to later stages, produced mainly by osteoclasts and used during bone remodeling. However, this repair capacity is limited and large bone defects require a lot of strength of the body, may leading to a bone repair not well structured. Thus, several proposed techniques to stimulate the development and use of bone grafts were effective to provide a framework for growth, facilitating the implementation of new bone and protecting the defect bed throughout the extended recovery period. This study focused on three different types of bone graft (autologous, homologous and heterologous) and their association with rhBMP-2 protein, evaluating the biochemical aspects according to the amount of MMP-2 and MMP-9 in two different periods of time. In general, it was found that firstly, there is an increased production of MMP-2, and MMP-9 levels remain relatively constant in both considered periods of time. The autologous graft presented the best results followed by homologous and heterologous, respectively; however the addition of rhBMP-2 in these grafts did not seem to influence the MMP-2 and MMP-9 levels, in both periods of time. The calcium dosage revealed more mineralization at the autologous and homologous groups, the other groups, besides having lower calcium levels, decreased these levels at the second period of this experiment.
Books on the topic "Rhbmp2"
McKay, William F. The rhBMP-2 reference guide. St. Louis, Mo: Quality Medical Pub., 2002.
Find full textBook chapters on the topic "Rhbmp2"
Voggenreiter, G., K. Hartl, S. Assenmacher, M. Chatzinikolaidou, and H. P. Jennissen. "Biologische Beschichtung von Implantaten mit rhBMP-2." In Deutsche Gesellschaft für Chirurgie, 453–55. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-56698-1_117.
Full textHerford, Alan, and Isaac Lowe. "The Role of rhBMP-2 in Oral and Maxillofacial Reconstruction." In Regenerative Strategies for Maxillary and Mandibular Reconstruction, 33–41. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-93668-0_4.
Full textSubach, B. R., R. W. Haid, Jr., G. E. Rodts, Jr., and C. A. Petraglia. "Bone Morphogenetic Protein (rhBMP-2): Experimental Review and Clinical Update." In Advances in Spinal Stabilization, 1–13. Basel: KARGER, 2003. http://dx.doi.org/10.1159/000072627.
Full textPeel, Sean A. F., Aileen J. J. Zhou, Hanje Chen, and Cameron M. L. Clokie. "Development of URIST™ a Multiphasic rhBMP-2 Bone Graft Substitute." In Clinical Applications of Biomaterials, 383–410. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56059-5_12.
Full textAlonso, Nivaldo, and Julia Amundson. "Bone Substitute: Alveolar Bone Grafting (ABG) with rhBMP-2 (Recombinant Bone Morphogenic Protein-2)." In Cleft Lip and Palate Treatment, 263–68. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-63290-2_17.
Full textUm, In Woong. "Demineralized Dentin Matrix (DDM) As a Carrier for Recombinant Human Bone Morphogenetic Proteins (rhBMP-2)." In Advances in Experimental Medicine and Biology, 487–99. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-0947-2_26.
Full textYao, Shaohua, Ling Li Zhang, Steven Y. Cheng, and Xing Dong Zhang. "Refolding and Purification of rhBMP-2 Expressed as Inclusion Bodies in E.COLI with Hydroxyapatite Chromatography." In Advanced Biomaterials VI, 661–64. Stafa: Trans Tech Publications Ltd., 2005. http://dx.doi.org/10.4028/0-87849-967-9.661.
Full textDuan, Bin, William W. Lu, and Min Wang. "Selective Laser Sintered Ca-P/PHBV Nanocomposite Scaffolds with Sustained Release of rhBMP-2 for Bone Tissue Engineering." In Advances in Bioceramics and Porous Ceramics IV, 37–48. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2011. http://dx.doi.org/10.1002/9781118095263.ch5.
Full textRuhé, P. Q., O. C. Boerman, F. G. M. Russel, P. H. M. Spauwen, Antonious G. Mikos, and John A. Jansen. "Controlled Release of rhBMP-2 Loaded Poly(DL-lactic-co-glycolic Acid)/ Calcium Phosphate Cement Composites In Vivo." In Bioceramics 18, 973–76. Stafa: Trans Tech Publications Ltd., 2006. http://dx.doi.org/10.4028/0-87849-992-x.973.
Full textMcKay, William F., Steven M. Peckham, and Jeffrey M. Badura. "Development of a novel compression-resistant carrier for recombinant human bone morphogenetic protein-2 (rhBMP-2) and preliminary clinical results." In Bone Morphogenetic Proteins: From Local to Systemic Therapeutics, 7–23. Basel: Birkhäuser Basel, 2008. http://dx.doi.org/10.1007/978-3-7643-8552-1_2.
Full textConference papers on the topic "Rhbmp2"
Piperdi, Sajida, David Geller, Amy Park, So Hak Chung, and Richard Gorlick. "Abstract 1630: Effects of rhBMP-2 on osteosarcoma tumorigenesis." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-1630.
Full textMcKay, B. "Local sustained delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2)." In 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2009. http://dx.doi.org/10.1109/iembs.2009.5332518.
Full textInoue, M., J. Tan, H. Tsujigiwa, Y. Kitamura, K. Hibi, Y. J. Lee, S. Kan, et al. "LONG-TERM OBSERVATION OF HETEROTOPIC BONE FORMATION INDUCED BY rhBMP-2 AND IBM COMPOSITES." In Proceedings of the 12th International Symposium on Ceramics in Medicine. WORLD SCIENTIFIC, 1999. http://dx.doi.org/10.1142/9789814291064_0063.
Full textKuboki, Y., H. Li, L. J. Bi, H. Kato, and H. Itoh. "TOOTH EXTRACTION SOCKETS EFFECTIVELY RECOVERED AFTER APPLICATION OF rhBMP-2 COMBINED WITH POROUS PARTICLES OF HYDROXYAPATITE." In Proceedings of the 12th International Symposium on Ceramics in Medicine. WORLD SCIENTIFIC, 1999. http://dx.doi.org/10.1142/9789814291064_0056.
Full textOhura, K., N. Matsuda, C. Hamanishi, and S. Tanaka. "BONE DEFECT REPAIR USING SUBCUTANEOUSLY INDUCED BONE BY A BIORESORBABLE CALCIUM PHOSPHATE CEMENT COMBINED WITH rhBMP-2." In Proceedings of the 12th International Symposium on Ceramics in Medicine. WORLD SCIENTIFIC, 1999. http://dx.doi.org/10.1142/9789814291064_0057.
Full textGeller, David S., So Hak Chung, Wendong Zhang, Sajida Piperdi, Carrie Freeman, Bang Hoang, Rui Yang, Michael Roth, Jonathan Gill, and Richard Gorlick. "Abstract 645: The effect of rhBMP-2 on in vitro osteosarcoma tumorigenesis and on pulmonary growth and development." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-645.
Full textIshimoto, Takatsugu, Keisuke Miyake, Masakazu Yashiro, Tsugio Eto, Daisuke Izumi, Kota Arima, Yoshifumi Baba, et al. "Abstract 4340: RHBDF2 in stromal fibroblasts mediates TGF-β signaling and enhances gastric cancer cell invasion via intercellular crosstalk." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-4340.
Full textBonello, Philip, and Pham Minh Hai. "Computational Studies of the Unbalance Response of a Whole Aero-Engine Model With Squeeze-Film Bearings." In ASME Turbo Expo 2009: Power for Land, Sea, and Air. ASMEDC, 2009. http://dx.doi.org/10.1115/gt2009-59687.
Full textHai, Pham Minh, and Philip Bonello. "A Computational Parametric Analysis of the Vibration of a Three-Spool Aero-Engine Under Multi-Frequency Unbalance Excitation." In ASME Turbo Expo 2010: Power for Land, Sea, and Air. ASMEDC, 2010. http://dx.doi.org/10.1115/gt2010-22801.
Full textLacunza, Ezequiel, Maria V. Croce, Ariel Zwenger, Amada Segal-Eiras, and Martín C. Abba. "Abstract 3801: Rhomboid domain containing 2 (RHBDD2) over-expression is associated to colorectal cancer progression and drug sensitivity to 5-FU treatment." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3801.
Full text